A real-world disproportionality analysis of Everolimus: data mining of the public version of FDA adverse event reporting system

• Main Authors: Bin Zhao (Author), Yumei Fu (Author), Shichao Cui (Author), Xiangning Chen (Author), Shu Liu (Author), Lan Luo (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Everolimus is an inhibitor of the mammalian target of rapamycin and is used to treat various tumors. The presented study aimed to evaluate the Everolimus-associated adverse events (AEs) through data mining of the US Food and Drug Administration Adverse Event Reporting System (FAERS).Meth...